688293 奥浦迈
午间休市 06-29 11:29:46
资讯
新帖
简况
每周股票复盘：奥浦迈（688293）股东减持1%股份成交额5616万元
证券之星 · 06-28 03:42
每周股票复盘：奥浦迈（688293）股东减持1%股份成交额5616万元
6月26日奥浦迈跌5.24%，招商医药健康产业股票基金重仓该股
证券之星 · 06-26 16:40
6月26日奥浦迈跌5.24%，招商医药健康产业股票基金重仓该股
奥浦迈（688293）披露持股5%以下特定股东权益变动触及1%刻度暨减持股份结果公告，6月25日股价下跌0.9%
证券之星 · 06-25
奥浦迈（688293）披露持股5%以下特定股东权益变动触及1%刻度暨减持股份结果公告，6月25日股价下跌0.9%
6月25日奥浦迈发布公告，股东减持139.27万股
证券之星 · 06-25
6月25日奥浦迈发布公告，股东减持139.27万股
6月24日奥浦迈发生1笔大宗交易 成交金额1178.7万元
证券之星 · 06-24
6月24日奥浦迈发生1笔大宗交易 成交金额1178.7万元
6月23日奥浦迈涨5.09%，招商医药健康产业股票基金重仓该股
证券之星 · 06-23
6月23日奥浦迈涨5.09%，招商医药健康产业股票基金重仓该股
奥浦迈涨5.09%，东吴证券一个月前给出“买入”评级
证券之星 · 06-23
奥浦迈涨5.09%，东吴证券一个月前给出“买入”评级
6月8日奥浦迈跌6.01%，招商医药健康产业股票基金重仓该股
证券之星 · 06-08
6月8日奥浦迈跌6.01%，招商医药健康产业股票基金重仓该股
每周股票复盘：奥浦迈（688293）股东减持4.28万股触及1%刻度
证券之星 · 06-07
每周股票复盘：奥浦迈（688293）股东减持4.28万股触及1%刻度
6月3日奥浦迈发布公告，股东减持4.28万股
证券之星 · 06-03
6月3日奥浦迈发布公告，股东减持4.28万股
6月2日奥浦迈跌8.34%，招商医药健康产业股票基金重仓该股
证券之星 · 06-02
6月2日奥浦迈跌8.34%，招商医药健康产业股票基金重仓该股
奥浦迈跌8.34% 2022年上市超募10亿元
中金财经 · 06-02
奥浦迈跌8.34% 2022年上市超募10亿元
奥浦迈（688293）披露2025年年度股东会决议公告，5月15日股价下跌0.6%
证券之星 · 05-15
奥浦迈（688293）披露2025年年度股东会决议公告，5月15日股价下跌0.6%
奥浦迈最新公告：股东拟合计减持不超4.00%股份
证券之星 · 05-11
奥浦迈最新公告：股东拟合计减持不超4.00%股份
奥浦迈（688293）披露2025年年度股东会会议资料，5月7日股价上涨1.76%
证券之星 · 05-07
奥浦迈（688293）披露2025年年度股东会会议资料，5月7日股价上涨1.76%
奥浦迈（688293）披露参加2025年度生物制品行业集体业绩说明会公告，5月6日股价上涨2.85%
证券之星 · 05-06
奥浦迈（688293）披露参加2025年度生物制品行业集体业绩说明会公告，5月6日股价上涨2.85%
奥浦迈（688293）2026年一季报简析：营收净利润同比双双增长，三费占比上升明显
证券之星 · 05-01
奥浦迈（688293）2026年一季报简析：营收净利润同比双双增长，三费占比上升明显
图解奥浦迈一季报：第一季度单季净利润同比增长167.45%
证券之星 · 04-30
图解奥浦迈一季报：第一季度单季净利润同比增长167.45%
4月23日奥浦迈跌6.15%，招商医药健康产业股票基金重仓该股
证券之星 · 04-23
4月23日奥浦迈跌6.15%，招商医药健康产业股票基金重仓该股
图解奥浦迈年报：第四季度单季净利润同比下降24.98%
证券之星 · 04-23
图解奥浦迈年报：第四季度单季净利润同比下降24.98%
加载更多
公司概况
公司名称：
上海奥浦迈生物科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2022-09-02
主营业务：
上海奥浦迈生物科技股份有限公司的主营业务是细胞培养产品与服务。公司的主要产品是CHO培养基、293培养基、CDMO服务。公司在2025浦东创新创业大会正式获授“大企业开放创新中心（GOI）”。大企业开放创新中心是浦东推动大企业携手创新企业共同成长的有效举措。本次公司获得授牌，不仅是对其产业龙头地位的认可，更标志着奥浦迈以“资本+平台”双轮驱动，系统化推进产业链开放创新的战略进入新阶段。
发行价格：
80.20
{"stockData":{"symbol":"688293","market":"SH","secType":"STK","nameCN":"奥浦迈","latestPrice":41.14,"timestamp":1782703786000,"preClose":37.65,"halted":0,"volume":2039254,"delay":0,"changeRate":0.0927,"floatShares":113999999,"shares":139000000,"eps":0.4758,"marketStatus":"午间休市","change":3.49,"latestTime":"06-29 11:29:46","open":37.61,"high":41.41,"low":37.13,"amount":81482600,"amplitude":0.1137,"askPrice":41.13,"askSize":50,"bidPrice":41.01,"bidSize":44,"shortable":0,"etf":0,"ttmEps":0.4758,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782709200000},"marketStatusCode":3,"adr":0,"adjPreClose":37.65,"symbolType":"stock_kcb","openAndCloseTimeList":[[1782696600000,1782703800000],[1782709200000,1782716400000]],"highLimit":41.42,"lowLimit":33.89,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":139271991,"isCdr":false,"pbRate":1.98,"roa":"--","peRate":86.464901,"roe":"1.44%","epsLYR":0.37,"committee":-0.028807,"marketValue":5730000000,"turnoverRate":0.0179,"status":0,"floatMarketCap":4683000000},"requestUrl":"/m/hq/s/688293","defaultTab":"news","newsList":[{"id":"2646315475","title":"每周股票复盘：奥浦迈（688293）股东减持1%股份成交额5616万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2646315475","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646315475?lang=zh_cn&edition=full","pubTime":"2026-06-28 03:42","pubTimestamp":1782589333,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，奥浦迈报收于37.65元，较上周的38.09元下跌1.16%。本周，奥浦迈6月24日盘中最高价报41.84元。奥浦迈当前最新总市值52.44亿元，在生物制品板块市值排名37/51，在两市A股市值排名3035/5206。来自股本股东变化：股东华杰投资减持139.27万股，持股比例由4.68%降至3.68%，减持金额5616.05万元。来自公司公告汇总：奥浦迈分期发行股份购买澎立生物资产，第一期发行2,895,808股，限售期12个月。交易信息汇总6月24日奥浦迈发生1笔大宗交易，成交金额1178.7万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800001155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646330494","title":"6月26日奥浦迈跌5.24%，招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646330494","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646330494?lang=zh_cn&edition=full","pubTime":"2026-06-26 16:40","pubTimestamp":1782463255,"startTime":"0","endTime":"0","summary":"证券之星消息，6月26日奥浦迈跌5.24%，收盘报37.65元，换手率2.31%，成交量2.63万手，成交额1.01亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共16家，其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。招商医药健康产业股票的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600030299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646801167","title":"奥浦迈（688293）披露持股5%以下特定股东权益变动触及1%刻度暨减持股份结果公告，6月25日股价下跌0.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646801167","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646801167?lang=zh_cn&edition=full","pubTime":"2026-06-25 22:59","pubTimestamp":1782399553,"startTime":"0","endTime":"0","summary":"截至2026年6月25日收盘，奥浦迈报收于39.73元，较前一交易日下跌0.9%，最新总市值为55.33亿元。近日，奥浦迈发布《关于持股5%以下特定股东权益变动触及1%刻度暨减持股份结果公告》。公告显示，华杰投资原持有奥浦迈4.68%股份，计划减持不超过公司总股本1.00%的股份。本次减持后持股比例降至3.68%，减持计划实施完毕。本次权益变动不触及要约收购，不影响公司控制权及治理结构。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500044683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646087066","title":"6月25日奥浦迈发布公告，股东减持139.27万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646087066","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646087066?lang=zh_cn&edition=full","pubTime":"2026-06-25 20:01","pubTimestamp":1782388882,"startTime":"0","endTime":"0","summary":"证券之星消息，6月25日奥浦迈发布公告《奥浦迈:关于持股5%以下特定股东权益变动触及1%刻度暨减持股份结果公告》，其股东宁波梅山保税港区铧杰股权投资管理有限公司-华杰(天津)医疗投资合伙企业(有限合伙)于2026年6月2日至2026年6月24日间合计减持139.27万股，占公司目前总股本的1.0%，变动期间该股股价下跌10.83%，截止6月24日收盘报40.09元。股东增减持详情见下表：根据奥浦迈2026年一季报公布的十大股东详情如下：本文数据来源于奥浦迈公告，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500039680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645990448","title":"6月24日奥浦迈发生1笔大宗交易 成交金额1178.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645990448","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645990448?lang=zh_cn&edition=full","pubTime":"2026-06-24 17:47","pubTimestamp":1782294474,"startTime":"0","endTime":"0","summary":"证券之星消息，6月24日奥浦迈发生大宗交易，交易数据如下：大宗交易成交价格39.29元，相对当日收盘价折价2%，成交30万股，成交金额1178.7万元，买方营业部为国信证券股份有限公司深圳金田路证券营业部，卖方营业部为国泰海通证券股份有限公司上海长宁区江苏路证券营业部。近三个月该股共发生1笔大宗交易，合计成交3000.0手，折价成交1笔。截至2026年6月24日收盘，奥浦迈报收于40.09元，下跌0.35%，换手率2.7%，成交量3.07万手，成交额1.25亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400033119.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645848508","title":"6月23日奥浦迈涨5.09%，招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645848508","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645848508?lang=zh_cn&edition=full","pubTime":"2026-06-23 16:51","pubTimestamp":1782204701,"startTime":"0","endTime":"0","summary":"证券之星消息，6月23日奥浦迈涨5.09%，收盘报40.23元，换手率2.09%，成交量2.38万手，成交额9486.53万元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共16家，其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。招商医药健康产业股票的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300028433.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645884859","title":"奥浦迈涨5.09%，东吴证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2645884859","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645884859?lang=zh_cn&edition=full","pubTime":"2026-06-23 16:51","pubTimestamp":1782204693,"startTime":"0","endTime":"0","summary":"今日奥浦迈（688293）涨5.09%，收盘报40.23元。2026年5月7日，东吴证券研究员朱国广,刘若彤发布了对奥浦迈的研报《2025年报&2026年一季报点评：培养基业务步入快速放量周期，CRO订单高增速》，该研报对奥浦迈给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为33.38%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为太平洋的李啸岩。奥浦迈（688293）个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300028429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641107598","title":"6月8日奥浦迈跌6.01%，招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641107598","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641107598?lang=zh_cn&edition=full","pubTime":"2026-06-08 16:43","pubTimestamp":1780908203,"startTime":"0","endTime":"0","summary":"证券之星消息，6月8日奥浦迈跌6.01%，收盘报35.2元，换手率2.53%，成交量2.88万手，成交额1.03亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共16家，其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。招商医药健康产业股票的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060800022206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641127125","title":"每周股票复盘：奥浦迈（688293）股东减持4.28万股触及1%刻度","url":"https://stock-news.laohu8.com/highlight/detail?id=2641127125","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641127125?lang=zh_cn&edition=full","pubTime":"2026-06-07 02:48","pubTimestamp":1780771694,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘，奥浦迈报收于37.45元，较上周的43.61元下跌14.13%。本周，奥浦迈6月1日盘中最高价报46.83元。本周关注点来自股本股东变化：股东减持4.28万股，占总股本0.0307%，触发权益变动1%披露标准。股本股东变化股东增减持6月3日奥浦迈发布公告，股东北京磐茂投资管理有限公司-磐信(上海)投资中心于2026年6月2日至6月3日合计减持4.28万股，占公司总股本的0.0307%，变动期间股价下跌10.54%。截至6月3日收盘价为40.22元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700000882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640901945","title":"6月3日奥浦迈发布公告，股东减持4.28万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640901945","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640901945?lang=zh_cn&edition=full","pubTime":"2026-06-03 20:01","pubTimestamp":1780488067,"startTime":"0","endTime":"0","summary":"证券之星消息，6月3日奥浦迈发布公告《奥浦迈:关于持股5%以上股东权益变动触及1%刻度的提示性公告》，其股东北京磐茂投资管理有限公司-磐信(上海)投资中心(有限合伙)于2026年6月2日至2026年6月3日间合计减持4.28万股，占公司目前总股本的0.0307%，变动期间该股股价下跌10.54%，截止6月3日收盘报40.22元。股东增减持详情见下表：根据奥浦迈2026年一季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300042708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640915165","title":"6月2日奥浦迈跌8.34%，招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640915165","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640915165?lang=zh_cn&edition=full","pubTime":"2026-06-02 16:33","pubTimestamp":1780389189,"startTime":"0","endTime":"0","summary":"证券之星消息，6月2日奥浦迈跌8.34%创60日新低，收盘报41.21元，换手率2.46%，成交量2.8万手，成交额1.17亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共16家，其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。招商医药健康产业股票的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200030891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640132219","title":"奥浦迈跌8.34% 2022年上市超募10亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2640132219","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640132219?lang=zh_cn&edition=full","pubTime":"2026-06-02 16:02","pubTimestamp":1780387326,"startTime":"0","endTime":"0","summary":"中国经济网北京6月2日讯 奥浦迈 今日收报41.21元，跌幅8.34%。该股目前处于破发状态。 奥浦迈于2022年9月2日在上交所科创板上市，公开发行新股2049.51万股，发行价格为80.20元/股，保荐机构为海通证券股份有限公司，保荐代表人为靳宇辰、王冰。 奥浦迈首次公开发行股票募集资金总额为164,370.56万元，扣除发行费用后，募集资金净额为151,094.48万元。 奥浦迈首次公开发行股票的发行费用总额为13,276.08万元，其中，保荐及承销费用11,505.94万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260602/32267556.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["IPOS","688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635035846","title":"奥浦迈（688293）披露2025年年度股东会决议公告，5月15日股价下跌0.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635035846","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635035846?lang=zh_cn&edition=full","pubTime":"2026-05-15 22:48","pubTimestamp":1778856496,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，奥浦迈报收于46.13元，较前一交易日下跌0.6%，最新总市值为64.25亿元。该股当日开盘46.22元，最高47.15元，最低45.87元，成交额达4660.55万元，换手率为0.88%。近日，奥浦迈发布《2025年年度股东会决议公告》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500044432.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634040423","title":"奥浦迈最新公告：股东拟合计减持不超4.00%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2634040423","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634040423?lang=zh_cn&edition=full","pubTime":"2026-05-11 17:25","pubTimestamp":1778491525,"startTime":"0","endTime":"0","summary":"奥浦迈(688293.SH)公告称，持股5%以上股东上海磐信计划自2026年6月2日起至2026年9月1日期间，通过大宗交易和集中竞价交易方式合计减持不超过278.54万股，占公司总股本不超过2.00%；国寿成达计划通过集中竞价交易方式减持不超过139.27万股，占公司总股本不超过1.00%；华杰投资计划通过大宗交易和集中竞价交易方式合计减持不超过139.27万股，占公司总股本不超过1.00%。减持原因为自身资金需求。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100023902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633126469","title":"奥浦迈（688293）披露2025年年度股东会会议资料，5月7日股价上涨1.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633126469","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633126469?lang=zh_cn&edition=full","pubTime":"2026-05-07 22:48","pubTimestamp":1778165297,"startTime":"0","endTime":"0","summary":"截至2026年5月7日收盘，奥浦迈报收于52.58元，较前一交易日上涨1.76%，最新总市值为73.23亿元。该股当日开盘52.32元，最高52.87元，最低51.44元，成交额达8139.54万元，换手率为1.37%。近日，奥浦迈发布《2025年年度股东会会议资料》。公告显示，公司2025年年度股东大会定于2026年5月15日召开，采用现场与网络投票相结合方式表决。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700041628.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633843501","title":"奥浦迈（688293）披露参加2025年度生物制品行业集体业绩说明会公告，5月6日股价上涨2.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633843501","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633843501?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:50","pubTimestamp":1778064634,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，奥浦迈报收于51.67元，较前一交易日上涨2.85%，最新总市值为71.96亿元。该股当日开盘50.24元，最高52.23元，最低49.72元，成交额达9444.09万元，换手率为1.61%。奥浦迈近日披露《关于参加十五五·科创惠民——科创板企业成果转化与民生赋能之2025年度生物制品行业集体业绩说明会的公告》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600032680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632141660","title":"奥浦迈（688293）2026年一季报简析：营收净利润同比双双增长，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2632141660","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632141660?lang=zh_cn&edition=full","pubTime":"2026-05-01 06:48","pubTimestamp":1777589321,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期奥浦迈发布2026年一季报。截至本报告期末，公司营业总收入1.82亿元，同比上升117.68%，归母净利润3922.89万元，同比上升167.45%。本报告期奥浦迈三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达48.55%。答：2025年,公司实现营业收入35,491.34万元,相较上年同期上升19.40%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100007257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631523341","title":"图解奥浦迈一季报：第一季度单季净利润同比增长167.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631523341","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631523341?lang=zh_cn&edition=full","pubTime":"2026-04-30 03:46","pubTimestamp":1777491987,"startTime":"0","endTime":"0","summary":"证券之星消息，奥浦迈2026年一季报显示，一季度公司主营收入1.82亿元，同比上升117.68%；归母净利润3922.89万元，同比上升167.45%；扣非净利润459.33万元，同比下降57.47%；负债率36.53%，投资收益389.36万元，财务费用212.23万元，毛利率43.79%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000010274.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629886688","title":"4月23日奥浦迈跌6.15%，招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629886688","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629886688?lang=zh_cn&edition=full","pubTime":"2026-04-23 16:27","pubTimestamp":1776932857,"startTime":"0","endTime":"0","summary":"证券之星消息，4月23日奥浦迈跌6.15%，收盘报49.74元，换手率1.39%，成交量1.58万手，成交额8004.9万元。重仓奥浦迈的前十大公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共16家，其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。该公募基金现任基金经理为李佳存。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300044800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629029968","title":"图解奥浦迈年报：第四季度单季净利润同比下降24.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629029968","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629029968?lang=zh_cn&edition=full","pubTime":"2026-04-23 01:08","pubTimestamp":1776877686,"startTime":"0","endTime":"0","summary":"证券之星消息，奥浦迈2025年年报显示，当年度公司主营收入3.55亿元，同比上升19.4%；归母净利润4169.85万元，同比上升98.07%；扣非净利润2084.9万元，同比上升216.57%；其中2025年第四季度，公司单季度主营收入8338.62万元，同比上升2.46%；单季度归母净利润-772.68万元，同比下降24.98%；单季度扣非净利润-1652.02万元，同比下降57.44%；负债率6.6%，投资收益2670.15万元，财务费用-910.29万元，毛利率50.85%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300002251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782708698203,"stockEarnings":[{"period":"1week","weight":-0.0116},{"period":"1month","weight":-0.1607},{"period":"3month","weight":-0.1558},{"period":"6month","weight":-0.2804},{"period":"1year","weight":-0.0397},{"period":"ytd","weight":-0.2316}],"compareEarnings":[{"period":"1week","weight":-0.0155},{"period":"1month","weight":-0.0162},{"period":"3month","weight":0.029},{"period":"6month","weight":0.016},{"period":"1year","weight":0.1678},{"period":"ytd","weight":0.0147}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海奥浦迈生物科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"4880人(较上一季度增加21.57%)","perCapita":"23323股","listingDate":"2022-09-02","address":"上海市浦东新区紫萍路908弄28号","registeredCapital":"13927万元","survey":" 上海奥浦迈生物科技股份有限公司的主营业务是细胞培养产品与服务。公司的主要产品是CHO培养基、293培养基、CDMO服务。公司在2025浦东创新创业大会正式获授“大企业开放创新中心（GOI）”。大企业开放创新中心是浦东推动大企业携手创新企业共同成长的有效举措。本次公司获得授牌，不仅是对其产业龙头地位的认可，更标志着奥浦迈以“资本+平台”双轮驱动，系统化推进产业链开放创新的战略进入新阶段。","listedPrice":80.2},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥浦迈(688293)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥浦迈(688293)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥浦迈,688293,奥浦迈股票,奥浦迈股票老虎,奥浦迈股票老虎国际,奥浦迈行情,奥浦迈股票行情,奥浦迈股价,奥浦迈股市,奥浦迈股票价格,奥浦迈股票交易,奥浦迈股票购买,奥浦迈股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥浦迈(688293)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥浦迈(688293)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}